These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32279775)

  • 1. Electrospun nanofibers for the delivery of active drugs through nasal, oral and vaginal mucosa: Current status and future perspectives.
    Sofi HS; Abdal-Hay A; Ivanovski S; Zhang YS; Sheikh FA
    Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110756. PubMed ID: 32279775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the design and development of "fast-dissolving" electrospun nanofibers based drug delivery systems - A systematic review.
    Balusamy B; Celebioglu A; Senthamizhan A; Uyar T
    J Control Release; 2020 Oct; 326():482-509. PubMed ID: 32721525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmucosal Delivery of Peptides and Proteins Through Nanofibers: Current Status and Emerging Developments.
    Gavali P; Desai J; Shah P; Sawarkar S
    AAPS PharmSciTech; 2024 Apr; 25(4):74. PubMed ID: 38575778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast Dissolving Oral Drug Delivery System Based on Electrospun Nanofibrous Webs of Cyclodextrin/Ibuprofen Inclusion Complex Nanofibers.
    Celebioglu A; Uyar T
    Mol Pharm; 2019 Oct; 16(10):4387-4398. PubMed ID: 31436100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic applications of electrospun nanofibers for drug delivery systems.
    Son YJ; Kim WJ; Yoo HS
    Arch Pharm Res; 2014 Jan; 37(1):69-78. PubMed ID: 24234913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric nanofibers: targeted gastro-retentive drug delivery systems.
    Malik R; Garg T; Goyal AK; Rath G
    J Drug Target; 2015 Feb; 23(2):109-24. PubMed ID: 25268275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoadhesive electrospun nanofibers for drug delivery systems: applications of polymers and the parameters' roles.
    Pérez-González GL; Villarreal-Gómez LJ; Serrano-Medina A; Torres-Martínez EJ; Cornejo-Bravo JM
    Int J Nanomedicine; 2019; 14():5271-5285. PubMed ID: 31409989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of lysozyme into a mucoadhesive electrospun patch for rapid protein delivery to the oral mucosa.
    Edmans JG; Murdoch C; Santocildes-Romero ME; Hatton PV; Colley HE; Spain SG
    Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110917. PubMed ID: 32409068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoadhesive polymers for oral transmucosal drug delivery: a review.
    Bagan J; Paderni C; Termine N; Campisi G; Lo Russo L; Compilato D; Di Fede O
    Curr Pharm Des; 2012; 18(34):5497-514. PubMed ID: 22632395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive microspheres: a promising tool in drug delivery.
    Patil SB; Sawant KK
    Curr Drug Deliv; 2008 Oct; 5(4):312-8. PubMed ID: 18855602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrospun nanofibers in drug delivery: recent developments and perspectives.
    Williams GR; Chatterton NP; Nazir T; Yu DG; Zhu LM; Branford-White CJ
    Ther Deliv; 2012 Apr; 3(4):515-33. PubMed ID: 22834080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoadhesive formulations: innovations, merits, drawbacks, and future outlook.
    Kumar A; Naik PK; Pradhan D; Ghosh G; Rath G
    Pharm Dev Technol; 2020 Sep; 25(7):797-814. PubMed ID: 32267180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrospun polymer micro/nanofibers as pharmaceutical repositories for healthcare.
    Feng X; Li J; Zhang X; Liu T; Ding J; Chen X
    J Control Release; 2019 May; 302():19-41. PubMed ID: 30922946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanofibers: An Effective Tool for Controlled and Sustained Drug Delivery.
    Singh A; Rath G; Singh R; Goyal AK
    Curr Drug Deliv; 2018 Feb; 15(2):155-166. PubMed ID: 28969554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal mucoadhesive drug delivery systems.
    de Araújo Pereira RR; Bruschi ML
    Drug Dev Ind Pharm; 2012 Jun; 38(6):643-52. PubMed ID: 21999572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications.
    Zhang H; Zhang J; Streisand JB
    Clin Pharmacokinet; 2002; 41(9):661-80. PubMed ID: 12126458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart polymers for controlled delivery of proteins and peptides: a review of patents.
    Fogueri LR; Singh S
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):40-8. PubMed ID: 19149728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
    Silva AC; Santos D; Ferreira D; Lopes CM
    Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral transmucosal drug delivery for pediatric use.
    Lam JK; Xu Y; Worsley A; Wong IC
    Adv Drug Deliv Rev; 2014 Jun; 73():50-62. PubMed ID: 23999459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles - important step towards effective mucosal vaccines.
    Mašek J; Lubasová D; Lukáč R; Turánek-Knotigová P; Kulich P; Plocková J; Mašková E; Procházka L; Koudelka Š; Sasithorn N; Gombos J; Bartheldyová E; Hubatka F; Raška M; Miller AD; Turánek J
    J Control Release; 2017 Mar; 249():183-195. PubMed ID: 27469472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.